Beijing Hotgen Biotech Co Ltd (688068) — Financial Flexibility Index
Beijing Hotgen Biotech Co Ltd (688068) has a Financial Flexibility Index of 0.06x as of September 2025. Free cash flow of CN¥17.78 Million (operating CF CN¥3.05 Million minus capex CN¥14.73 Million) represents 0% of total liabilities (CN¥278.25 Million). Check 688068 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Beijing Hotgen Biotech Co Ltd Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Beijing Hotgen Biotech Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see Beijing Hotgen Biotech Co Ltd cash flow conversion.
Annual Financial Flexibility Index for Beijing Hotgen Biotech Co Ltd (2016–2024)
Year-by-year free cash flow to debt coverage for Beijing Hotgen Biotech Co Ltd. Explore Beijing Hotgen Biotech Co Ltd (688068) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.06x | CN¥14.24 Million | CN¥-37.16 Million | CN¥251.77 Million | ▼ -97.0% |
| 2023 | 1.92x | CN¥387.98 Million | CN¥-25.39 Million | CN¥202.56 Million | ▼ -32.3% |
| 2022 | 2.83x | CN¥1.54 Billion | CN¥978.75 Million | CN¥545.59 Million | ▼ -28.3% |
| 2021 | 3.95x | CN¥3.04 Billion | CN¥2.64 Billion | CN¥771.01 Million | ▲ +82.5% |
| 2020 | 2.16x | CN¥336.89 Million | CN¥164.62 Million | CN¥155.72 Million | ▲ +53.2% |
| 2019 | 1.41x | CN¥107.86 Million | CN¥19.37 Million | CN¥76.37 Million | ▼ -17.5% |
| 2018 | 1.71x | CN¥97.04 Million | CN¥55.04 Million | CN¥56.68 Million | ▼ -47.9% |
| 2017 | 3.29x | CN¥92.00 Million | CN¥22.95 Million | CN¥28.00 Million | ▲ +43.5% |
| 2016 | 2.29x | CN¥66.72 Million | CN¥45.54 Million | CN¥29.14 Million | — |